⚙

Pathophysiology Nodes

5
5 shared nodes are defined in this module.
◉

Cell Types

1
vascular associated smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this mechanism module involves this cell type This mechanism module involves vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
⇄

Biological Processes

3
elastic fiber assembly GO:0048251 ↓ DECREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves decreased elastic fiber assembly (GO:0048251). GO:0048251 is a biological process from the Gene Ontology. transforming growth factor beta receptor signaling pathway GO:0007179 ↑ INCREASED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves increased transforming growth factor beta receptor signaling pathway (GO:0007179). GO:0007179 is a biological process from the Gene Ontology. extracellular matrix organization GO:0030198 ↕ DYSREGULATED Gene Ontology (GO) Relation: this mechanism module involves this biological process This mechanism module involves dysregulated extracellular matrix organization (GO:0030198). GO:0030198 is a biological process from the Gene Ontology.
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "aortopathy_tgfbeta_dysregulation#TGF-beta Signaling Dysregulation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should substitute the disorder-specific primary lesion while preserving the conserved cascade. Key disorder-specific substitutions: Marfan and Shprintzen-Goldberg use FBN1 microfibril deficiency (with SKI in Shprintzen-Goldberg); Loeys-Dietz uses TGF-beta pathway gene mutations (TGFBR1/2, SMAD3, TGFB2/3); vascular Ehlers-Danlos uses COL3A1; arterial tortuosity syndrome uses SLC2A10 (GLUT10); and nonsyndromic familial TAAD uses smooth muscle contractile-apparatus genes (ACTA2, MYH11, MYLK, PRKG1). The shared hub and key conformance target is "TGF-beta Signaling Dysregulation". Evidence here is drawn from cross-TAAD reviews documenting the conserved cascade rather than any single disease; evidence_source is OTHER because these are reviews synthesizing multiple study types.
↗

Used By Disorder Entries

14
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Aortopathy TGF-beta Dysregulation Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

5
Aortic Wall ECM or Contractile Apparatus Defect
trigger
A monogenic loss-of-function or dominant-negative defect compromises a structural or regulatory component of the aortic wall: the fibrillin-1 microfibrils and elastic fibers of the extracellular matrix (FBN1, COL3A1, and other matrix genes), or the contractile apparatus of vascular smooth muscle cells (ACTA2, MYH11, MYLK, PRKG1). The identity of the affected gene varies by disorder, but loss of normal aortic wall architecture is the conserved trigger.
vascular associated smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
elastic fiber assembly GO:0048251 ↓ DECREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased elastic fiber assembly (GO:0048251). GO:0048251 is a biological process from the Gene Ontology.
Show evidence (3 references)
PMID:24925629 SUPPORT Other
"Marfan syndrome (MFS) is an inherited autosomal dominant multisystem disease caused by mutations in the FBN1 gene encoding fibrillin-1, an extracellular matrix glycoprotein widely distributed in mesenchymal-derived tissues that provide a scaffold for elastin deposition."
Documents the prototypical structural trigger (FBN1 microfibril/elastin deficiency) of the heritable aortopathies. Evidence source is OTHER because this is a review of Marfan aortopathy.
PMID:24016541 SUPPORT Other
"Mutations in multiple genes affecting proteins in the extracellular matrix, microfibrillar structure, the endothelium and cell signalling pathways have been associated with thoracic aortic disease."
Confirms that the conserved trigger spans multiple gene classes affecting extracellular matrix and microfibrillar structure. Evidence source is OTHER because this is a review of heritable aortopathies.
PMID:27375798 SUPPORT Other
"genetic mutation could be identified in some proteins such as smooth muscle cell α-actin (ACTA2), myosin heavy chain 11 (MYH11) or SMAD3"
Documents the smooth muscle contractile-apparatus arm of the trigger (ACTA2, MYH11), complementing the ECM arm. Evidence source is OTHER because this is a review of aortic aneurysm etiopathogenesis.
TGF-beta Signaling Dysregulation
central effector
The diverse primary lesions converge on dysregulated, paradoxically increased TGF-beta signaling in the aortic wall. TGF-beta signaling is central to vascular smooth muscle cell differentiation, matrix production, and vascular homeostasis, so its dysregulation is the shared hub event of the heritable aortopathies and the key conformance target for disorder entries. Notably, even loss-of-function mutations in TGF-beta receptors produce increased aortic TGF-beta activity (the "TGF-beta paradox").
vascular associated smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
transforming growth factor beta receptor signaling pathway GO:0007179 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased transforming growth factor beta receptor signaling pathway (GO:0007179). GO:0007179 is a biological process from the Gene Ontology.
Show evidence (3 references)
PMID:24016541 SUPPORT Other
"The TGFß signalling pathway appears to play a key role in mediating abnormal aortic growth and aneurysm formation."
Establishes the TGF-beta pathway as the key mediator of abnormal aortic growth and aneurysm formation, the central hub of this module. Evidence source is OTHER because this is a review.
PMID:30037098 SUPPORT Other
"not only structural weakness of connective tissue but also increased TGF-β signaling contributes to the complicated pathogenesis of aortic aneurysm formation"
Confirms increased TGF-beta signaling (beyond structural weakness) as a driver of aortic aneurysm pathogenesis. Evidence source is OTHER because this is a review.
PMID:30037098 SUPPORT Other
"Heterozygous loss-of-function mutations in TGF-β receptors 1 and 2 (TGFBR1 and TGFBR2) cause LDS, but TGF-β signaling is activated in the aorta (referred to as the TGF-β paradox) by mechanisms yet to be elucidated."
Documents the conserved convergence on increased aortic TGF-beta activity even with loss-of-function receptor mutations (the TGF-beta paradox). Evidence source is OTHER because this is a review.
Aortic Medial Degeneration and Wall Weakening
effector
The structural defect and dysregulated TGF-beta signaling drive the histologic hallmark of the aortopathies, medial degeneration: disarray and fragmentation of elastic fibers, depletion of smooth muscle cells, and accumulation of disordered ground-substance matrix. Aberrant TGF-beta signaling, as a consequence of the altered matrix, activates Smad-dependent profibrotic signaling and increased matrix metalloproteinase synthesis, degrading the layered architecture of the media and weakening the wall. This process is conserved across the heritable aortopathies regardless of the initiating gene.
vascular associated smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
extracellular matrix organization GO:0030198 ↕ DYSREGULATED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated extracellular matrix organization (GO:0030198). GO:0030198 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:24925629 SUPPORT Other
"Histological aspects of MFS aortopathy include a medial degeneration from disarray and fragmentation of elastic fibers and accumulation of basophilic ground substance areas depleted of smooth muscle cells (SMCs)."
Directly defines the conserved medial-degeneration effector — elastic fiber fragmentation and smooth muscle cell depletion — as the histologic hallmark of the aortopathy. Evidence source is OTHER because this is a review.
PMID:24925629 SUPPORT Other
"The aberrant signaling of transforming growth factor-β (TGF-β) as the consequence of the altered structure of fibrillin-1 induces activation and the overexpression of Smad-dependent profibrotic signaling pathway and ERK1/2-mediated increased synthesis of matrix metalloproteinases."
Documents the conserved molecular link from altered matrix to TGF-beta driven profibrotic signaling and matrix metalloproteinase synthesis that degrades the media. Evidence source is OTHER because this is a review.
Progressive Aortic Dilation and Aneurysm
effector
The structurally weakened aortic wall cannot withstand pulsatile hemodynamic stress and progressively dilates, characteristically at the aortic root and ascending aorta, forming an aneurysm. The natural history of this dilation is progressive expansion, and aortic root aneurysms are the common problem across the syndromic aortopathies.
Show evidence (2 references)
PMID:30037098 SUPPORT Other
"Aortic root aneurysms are common problems that can result in aortic dissection or rupture, which is the leading cause of sudden death in the natural history of"
Establishes aortic root aneurysm as the common, conserved manifestation that progresses toward dissection or rupture. Evidence source is OTHER because this is a review.
PMID:28607545 SUPPORT Other
"the natural history of aneurysmal dilation is progressive expansion, occasionally culminating in catastrophic consequences such as dissection or rupture"
Documents the conserved progressive-dilation natural history that defines this effector node. Evidence source is OTHER because this is a review.
Aortic Dissection and Rupture
consequence
The conserved terminal consequence of the heritable aortopathies. The degenerated, dilated aortic wall is prone to dissection and rupture, the main life-threatening manifestation and leading cause of premature death. These complications give the aortopathies their clinical urgency and motivate surveillance and prophylactic repair across all conforming disorders.
Show evidence (2 references)
PMID:24925629 SUPPORT Other
"ascending aortic aneurysm with ensuing dissection and rupture is the main life-threatening cardiovascular manifestation of MFS."
Establishes dissection and rupture as the conserved, life-threatening terminal consequence of the aortopathy. Evidence source is OTHER because this is a review.
PMID:28607545 SUPPORT Other
"thoracic aortic aneurysm dissection (TAAD) is an important cause of premature death in young adults"
Confirms aortic dissection as an important cause of premature death, the high-mortality endpoint shared across the heritable aortopathies. Evidence source is OTHER because this is a review.